Skip to main content
Clinical Trials/NCT04211298
NCT04211298
Unknown
Phase 4

Dexmedetomidine Versus Propofol Sedation in Flexible Bronchoscopy: A Randomized Controlled Trial

Rabin Medical Center1 site in 1 country100 target enrollmentDecember 1, 2019

Overview

Phase
Phase 4
Intervention
Propofol
Conditions
Sedation Complication
Sponsor
Rabin Medical Center
Enrollment
100
Locations
1
Primary Endpoint
number of de-saturation events
Last Updated
6 years ago

Overview

Brief Summary

The study will evaluate clinical outcomes during bronchoscopy procedures with dexmedetomidine in comparison to propofol.

The clinical outcomes that will be evaluated are: oxygen saturation, transcutaneous Pco2, blood pressure and complications

Registry
clinicaltrials.gov
Start Date
December 1, 2019
End Date
August 1, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mordechai Kremer

Head of the pulmonary division

Rabin Medical Center

Eligibility Criteria

Inclusion Criteria

  • All patients in the age group 18 to 70 years requiring flexible bronchoscopic evaluation of the airway in the Pulmonary institute at Rabin medical center

Exclusion Criteria

  • known or suspected allergy to any of the study drugs, seizure disorder, renal (with serum creatinine \> 2 mg/dL) or hepatic impairment (elevated liver enzymes \> 2 times normal), haemodynamic instability (bradycardia with HR \< 50 bpm or hypotension with SBP \< 90 mmHg), or seriously ill patients with American Society of Anesthesiologists' physical status above III

Arms & Interventions

Propofol

Propofol will be used for sedation during bronchoscopy

Intervention: Propofol

Dexmedetomidine

Dexmedetomidine will be used for sedation during bronchoscopy

Intervention: Dexmedetomidine

Outcomes

Primary Outcomes

number of de-saturation events

Time Frame: During the procedure

Number of events during bronchoscopy when saturation level decreased under 90%

Oxygen saturation time < 90%

Time Frame: During the procedure

Total time during the procedure that the oxygen saturation was under 90%

Study Sites (1)

Loading locations...

Similar Trials